Follow us
HOME
OUR STORY
TRACK RECORD
TEAM
INVESTORS
FUNDS
PORTFOLIO
IMPACT
SFDR
NEWS
CONTACT
No
Yes
Ok
LSP COMPANY NEWS
LSP portfolio company Artios Pharma announces collaboration with Novartis
read full story
LSP COMPANY NEWS
LSP portfolio company Binx Health receives FDA CLIA Waiver
read full story
LSP COMPANY NEWS
Endotronix Celebrates 100th Implant Of The Cordella™ Pulmonary Artery Pressure Sensor
read full story
LSP ANNOUNCES CLOSING
OF UPSIZED $120 MILLION NASDAQ IPO
read full story
LSP COMPANY NEWS
LSP portfolio company binx health collaborates with Amazon Business
LSP COMPANY NEWS
LSP portfolio company Nouscom receives approval to begin Phase 1b trials of NOUS-PEV
read full story
LSP COMPANY NEWS
LSP’s portfolio company Simplify Medical acquired by NuVasive
read full story
LSP PORTFOLIO COMPANY
Artios Pharma Announces the Start of First Clinical Study
read full story
LSP COMPANY NEWS
LSP portfolio company Pharvaris successfully lists on Nasdaq
read full story
go to archive
Follow us
Menu
HOME
OUR STORY
TRACK RECORD
TEAM
INVESTORS
FUNDS
PORTFOLIO
IMPACT
SFDR
NEWS
CONTACT
No
Yes
Ok
LSP Portfolio Company Artios Pharma Announces Collaboration with Novartis to Create New Cancer Therapies
Binx Health receives FDA CLIA Waiver for Chlamydia and Gonorrhea test
Endotronix Celebrates 100th Implant Of The Cordella™ Pulmonary Artery Pressure Sensor
LSP ANNOUNCES CLOSING OF UPSIZED $120 MILLION NASDAQ IPO
LSP portfolio company binx health collaborates with A...
Nouscom receives approval to begin Phase 1b trials of NOUS-PEV
LSP’s portfolio company Simplify Medical acquired by NuVasive
Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients
LSP portfolio company Pharvaris successfully lists on Nasdaq
go to archive
X
MONTHLY REPORTS
Here you can subscribe for the monthly report of the LSP Life Sciences Fund
First Name:
Last Name:
Email:*
Company: